한국형 양극성 장애 약물치료 알고리듬 2022: 유지치료

• 영문명: Korean Medication Algorithm Project for Bipolar Disorder 2022: Maintenance Therapy
• 발행기관: 대한신경정신의학회
• 저자명: 이정구 박원명 우영섭 정종현 서정석 추일한 양찬모 김원 심세훈 정명훈 전덕인 박성용 손인기 김문두 윤보현
• 간행물 정보: 『신경정신의학』제61권 제3호, 214~223쪽, 전체 10쪽
• 주제분류: 의약학 > 정신과학
• 파일형태: PDF
• 발행일자: 2022.08.31

영문 초록

Objectives In this study, we investigated and organized the maintenance-treatment strategies for Bipolar I and II disorders outlined in The Korean Medication Algorithm Project for Bipolar disorder 2022 (KMAP-BP 2022). Methods The questionnaire sought to survey expert opinion on medication for bipolar disorders and was completed by a review committee consisting of 87 experienced Korean psychiatrists. It comprised 56 questions, and each question included various sub-items. The questionnaire for the maintenance treatments covered overall treatment strategies after acute mood episodes in bipolar I and II disorders, the choice of mood stabilizers and atypical antipsychotics and antidepressants, duration of medication, and treatment strategies for breakthrough symptoms. Results In the case of bipolar I disorder, mood stabilizer monotherapy, atypical antipsychoticsmonotherapy, and a combination of mood stabilizers and atypical antipsychotics were selectedas the first-line treatments. In maintenance management of bipolar II disorder, mood stabilizermonotherapy, atypical antipsychotics monotherapy, and combinations of mood stabilizers wereselected as the preferred first-line treatments. Conclusion There has been a growing body of evidence that atypical antipsychotics have agreater preference than observed in the previous KMAP-BP of 2018. Also, monotherapy ofmood stabilizers or atypical antipsychotics was more frequently selected in KMAP-BP 2022 thanin the KMAP-BP 2018.

목차

서 론

방 법

결 과

고 찰

결 론

REFERENCES

키워드

양극성 장애 유지치료 Bipolar disorder KMAP-BP 2022 Maintenance therapy